Host and viral factors that determine the clinical outcome of hepatitis C virus genotype 3a infection
<p>HCV infects 170 million persons worldwide and is a serious global health problem. Genotype-3a is the dominant genotype in newly diagnosed infections within the UK and has a high response rate to interferon therapy, with up to 70% patients achieving a sustained virological response (SVR). Th...
Հիմնական հեղինակներ: | Humphreys, I, Isla S. Humphreys |
---|---|
Այլ հեղինակներ: | Barnes, E |
Ձևաչափ: | Թեզիս |
Լեզու: | English |
Հրապարակվել է: |
2011
|
Խորագրեր: |
Նմանատիպ նյութեր
-
Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
: Hennig, B, և այլն
Հրապարակվել է: (2008) -
Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
: Antrobus, R
Հրապարակվել է: (2014) -
Use of genome wide expression profiles in analysis of T cell dysfunction in Hepatitis C virus infection
: Gupta, P
Հրապարակվել է: (2014) -
Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
: Kelly, C
Հրապարակվել է: (2013) -
Aspects to T-cell phenotype during infection with HIV, CMV and Hepatitis C virus
: Northfield, J
Հրապարակվել է: (2008)